{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:49Z","timestamp":1791143329572,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100011734","name":"Chronic Granulomatous Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Commission E-Rare program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Patients with chronic granulomatous disease (CGD) suffer from recurrent, life-threatening bacterial and fungal infections of the skin, the airways, the lymph nodes, liver, brain and bones. Frequently found pathogens are Staphylococcus aureus, Aspergillus species, Klebsiella species, Burkholderia cepacia and Salmonella species. CGD is a rare (\u223c1:250 000 births) disease caused by mutations in any one of the five components of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. This enzyme generates superoxide and is essential for intracellular killing of pathogens by phagocytes. Molecular diagnosis of CGD involves measuring NADPH oxidase activity in phagocytes, measuring protein expression of NADPH oxidase components and mutation analysis of genes encoding these components. Residual oxidase activity is important to know for estimation of the clinical course and the chance of survival of the patient. Mutation analysis is mandatory for genetic counselling and prenatal diagnosis. This review summarizes the different assays available for the diagnosis of CGD, the precautions to be taken for correct measurements, the flow diagram to be followed, the assays for confirmation of the diagnosis and the determinations for carrier detection and prenatal diagnosis.<\/jats:p>","DOI":"10.1111\/cei.12202","type":"journal-article","created":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T22:45:15Z","timestamp":1378853115000},"page":"139-149","source":"Crossref","is-referenced-by-count":140,"title":["Molecular diagnosis of chronic granulomatous disease"],"prefix":"10.1093","volume":"175","author":[{"given":"D","family":"Roos","sequence":"first","affiliation":[{"name":"Deptartment of Blood Cell Research, Sanquin Blood Supply Organization, Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boer","sequence":"additional","affiliation":[{"name":"Deptartment of Blood Cell Research, Sanquin Blood Supply Organization, Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"key":"2021111804104703200_cei12202-bib-0001","volume-title":"Primary immunodeficiency diseases. A molecular and genetic approach","author":"Roos","year":"2013","edition":"3rd"},{"key":"2021111804104703200_cei12202-bib-0002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/416291a","article-title":"Killing activity of neutrophils is mediated through activation of proteases by K+ flux","volume":"416","author":"Reeves","year":"2002","journal-title":"Nature"},{"key":"2021111804104703200_cei12202-bib-0003","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI2301","article-title":"Virulence of catalase-deficient Aspergillus nidulans in p47-phox\u2013\/\u2013 mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease","volume":"101","author":"Chang","year":"1998","journal-title":"J Clin Invest"},{"key":"2021111804104703200_cei12202-bib-0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)02658-3","article-title":"Catalase-negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease","volume":"518","author":"Messina","year":"2002","journal-title":"FEBS Lett"},{"key":"2021111804104703200_cei12202-bib-0005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional and genetic characterization of eighty-nine patients in Turkey with chronic granulomatous disease","volume":"132","author":"K\u00f6ker","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021111804104703200_cei12202-bib-0006","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"2021111804104703200_cei12202-bib-0007","first-page":"213","article-title":"Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease","volume":"18","author":"Ho","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"2021111804104703200_cei12202-bib-0008","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hematopoietic allograft: a survey of the European experience 1985\u20132000","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"key":"2021111804104703200_cei12202-bib-0009","first-page":"1087","article-title":"Chronic granulomatous disease \u2013 haematopoietic stem cell transplantation versus conventional treatment","volume":"102","author":"\u00c5hlin","year":"2013","journal-title":"Acta Paediatr"},{"key":"2021111804104703200_cei12202-bib-0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"2021111804104703200_cei12202-bib-0011","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1073\/pnas.94.22.12133","article-title":"Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease","volume":"94","author":"Malech","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804104703200_cei12202-bib-0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0076-6879(86)32010-X","article-title":"Purification and cryopreservation of phagocytes from human blood","volume":"132","author":"Roos","year":"1986","journal-title":"Meth Enzymol"},{"key":"2021111804104703200_cei12202-bib-0013","first-page":"570","article-title":"Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study","volume":"83","author":"Weening","year":"1974","journal-title":"J Lab Clin Med"},{"key":"2021111804104703200_cei12202-bib-0014","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-1-59745-467-4_31","article-title":"Diagnostic assays for chronic granulomatous disease and other neutrophil disorders","volume":"412","author":"Elloumi","year":"2007","journal-title":"Methods Mol Biol"},{"key":"2021111804104703200_cei12202-bib-0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jlb.39.6.699","article-title":"Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test","volume":"39","author":"Meerhof","year":"1986","journal-title":"J Leukoc Biol"},{"key":"2021111804104703200_cei12202-bib-0016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-008-0129-0","article-title":"Remarks on the article Genetics and immunopathology of chronic granulomatous disease by Marie Jos\u00e9 Stasia and Xing Jun Li","volume":"30","author":"Roesler","year":"2008","journal-title":"Semin Immunopathol"},{"key":"2021111804104703200_cei12202-bib-0017","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-59745-467-4_23","article-title":"Measurement of respiratory burst products generated by professional phagocytes","volume":"412","author":"Dahlgren","year":"2007","journal-title":"Methods Mol Biol"},{"key":"2021111804104703200_cei12202-bib-0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cyto.990180306","article-title":"Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions","volume":"18","author":"Emmend\u00f6rffer","year":"1994","journal-title":"Cytometry"},{"key":"2021111804104703200_cei12202-bib-0019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0022-1759(96)00024-5","article-title":"Limitations on the use of dihydrorhodamine-1,2,3 for flow cytometric analysis of the neutrophil respiratory burst","volume":"191","author":"Van Pelt","year":"1996","journal-title":"J Immunol Methods"},{"key":"2021111804104703200_cei12202-bib-0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0022-3476(96)70437-7","article-title":"Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease","volume":"128","author":"Vowells","year":"1996","journal-title":"J Pediatr"},{"key":"2021111804104703200_cei12202-bib-0021","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1373\/clinchem.2006.083444","article-title":"Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD","volume":"53","author":"Mauch","year":"2007","journal-title":"Clin Chem"},{"key":"2021111804104703200_cei12202-bib-0022","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1348-0421.2001.tb02614.x","article-title":"Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox","volume":"45","author":"Yamauchi","year":"2001","journal-title":"Microbiol Immunol"},{"key":"2021111804104703200_cei12202-bib-0023","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2362.2009.02195.x","article-title":"Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations","volume":"39","author":"K\u00f6ker","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"2021111804104703200_cei12202-bib-0024","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","article-title":"A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity","volume":"114","author":"Matute","year":"2009","journal-title":"Blood"},{"key":"2021111804104703200_cei12202-bib-0025","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1073\/pnas.080074897","article-title":"Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation","volume":"97","author":"Ambruso","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804104703200_cei12202-bib-0026","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood.V100.3.1026","article-title":"Deletion of leucine-61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections","volume":"100","author":"Van Bruggen","year":"2002","journal-title":"Blood"},{"key":"2021111804104703200_cei12202-bib-0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-1-59745-467-4_25","article-title":"The reductionist approach to the study of NADPH oxidase assembly, or \u2018all you wanted to know about cell-free assays but did not dare to ask\u2019","volume":"412","author":"Molshanski-Mor","year":"2007","journal-title":"Methods Mol Biol"},{"key":"2021111804104703200_cei12202-bib-0028","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.1073\/pnas.89.21.10174","article-title":"O2\u2212 production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA","volume":"89","author":"Chanock","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804104703200_cei12202-bib-0029","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0301-472X(01)00731-7","article-title":"Gene-scan method for the recognition of carriers and patients with p47-phox-deficient autosomal recessive chronic granulomatous disease","volume":"29","author":"Dekker","year":"2001","journal-title":"Exp Hematol"},{"key":"2021111804104703200_cei12202-bib-0030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/humu.20413","article-title":"Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase","volume":"27","author":"Roos","year":"2006","journal-title":"Hum Mutat"},{"key":"2021111804104703200_cei12202-bib-0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1098-1004(1999)13:1<29::AID-HUMU3>3.0.CO;2-X","article-title":"Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox","volume":"13","author":"Pati\u00f1o","year":"1999","journal-title":"Human Mutat"},{"key":"2021111804104703200_cei12202-bib-0032","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.molimm.2009.03.016","article-title":"Molecular characterization of a large cohort of patients with chronic granulomatous disease and identification of novel CYBB mutations: an Italian multicenter study","volume":"46","author":"Di Matteo","year":"2009","journal-title":"Mol Immunol"},{"key":"2021111804104703200_cei12202-bib-0033","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2353\/jmoldx.2010.090147","article-title":"Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting","volume":"12","author":"Hill","year":"2010","journal-title":"J Mol Diagn"},{"key":"2021111804104703200_cei12202-bib-0034","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"2021111804104703200_cei12202-bib-0035","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.drudis.2008.06.007","article-title":"The array CGH and its clinical applications","volume":"13","author":"Shinawi","year":"2008","journal-title":"Drug Discov Today"},{"key":"2021111804104703200_cei12202-bib-0036","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10875-012-9667-2","article-title":"Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families","volume":"32","author":"Stasia","year":"2012","journal-title":"J Clin Immunol"},{"key":"2021111804104703200_cei12202-bib-0037","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ejhg.2012.310","article-title":"Functional and genetic characterization of two extremely rare cases of Williams\u2013Beuren syndrome associated with chronic granulomatous disease","volume":"21","author":"Stasia","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"2021111804104703200_cei12202-bib-0038","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM197901253000406","article-title":"Prenatal diagnosis of chronic granulomatous disease","volume":"300","author":"Newburger","year":"1979","journal-title":"N Engl J Med"},{"key":"2021111804104703200_cei12202-bib-0039","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/pd.1970120910","article-title":"Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction","volume":"12","author":"De Boer","year":"1992","journal-title":"Prenat Diagn"},{"key":"2021111804104703200_cei12202-bib-0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pd.296","article-title":"Prenatal diagnosis in two families with autosomal, p47-phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1","volume":"22","author":"De Boer","year":"2002","journal-title":"Prenat Diagn"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12202","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/175\/2\/139\/41082964\/cei12202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/175\/2\/139\/41082964\/cei12202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:25:20Z","timestamp":1641036320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/175\/2\/139\/6378137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,1,3]]},"published-print":{"date-parts":[[2014,1,3]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12202","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,2]]},"published":{"date-parts":[[2014,1,3]]}}}